DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Burnett AK, Milligan D, Prentice AG et al.
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.
Cancer 2007;
109: 1114-1124
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.